Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurogenic Detrusor Overactivity”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Large-scale testing (Phase 3)Study completedNCT02501928
What this trial is testing

Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.

Who this might be right for
Urinary Bladder, Neurogenic
Pfizer 12
Testing effectiveness (Phase 2)Ended earlyNCT00712322
What this trial is testing

A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Warner Chilcott 35
Not applicableStudy completedNCT01629433
What this trial is testing

Onabotulinumtoxina Intradetrusorial Injections and NGF Expression

Who this might be right for
Overactive DetrusorDetrusor Hyperreflexia of Bladder
University Of Perugia 25
Testing effectiveness (Phase 2)Study completedNCT00583219
What this trial is testing

Botulin-A Toxin Instillations and Overactive Bladder

Who this might be right for
Overactive BladderDetrusor InstabilityDetrusor Hyperreflexia
Mayo Clinic 25
Not applicableStudy completedNCT02072928
What this trial is testing

Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence From Neurogenic Detrusor Overactivity in Belgium

Who this might be right for
Urinary Incontinence
Allergan 55
Not applicableStudy completedNCT04543552
What this trial is testing

A Comparative Analysis of Portable Bladder Scanner to Determine Age/ Volume Specific Accuracy in 0-6 Years of Children

Who this might be right for
Neurogenic BladderDetrusor UnderactivityDetrusor Overactivity
Seoul National University Hospital 34
Early research (Phase 1)Study completedNCT04452838
What this trial is testing

Study To Assess The Bioequivalence Under Fed And Fasted Conditions Of The Fesoterodine Beads-In-Capsule SR4 And SR7 Formulations And To Estimate The Bioavailability of SR7 Beads Sprinkled On Apple Sauce Relative To The Beads-In-Capsule SR7 Formulation Administer

Who this might be right for
Neurogenic Detrusor Overactivity
Pfizer 37
Testing effectiveness (Phase 2)Study completedNCT00857896
What this trial is testing

Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Pfizer 21
Large-scale testing (Phase 3)Study completedNCT02849418
What this trial is testing

Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity

Who this might be right for
Urinary Bladder, Overactive
GlaxoSmithKline 21
Large-scale testing (Phase 3)Ended earlyNCT02660359
What this trial is testing

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2

Who this might be right for
Urinary IncontinenceOveractive Bladder
Ipsen 258
Not applicableStudy completedNCT05504200
What this trial is testing

Transcutaneous Spinal Cord Stimulation With Bladder and Pelvic Floor Muscle Training

Who this might be right for
Spinal Cord Injuries
RNOH RIC 15
Not applicableStudy completedNCT01297660
What this trial is testing

Neuro-urological Outcome After Spinal Cord Injury

Who this might be right for
Urinary Bladder Neurogenic Dysfunction
Balgrist University Hospital 55
Early research (Phase 1)Study completedNCT02526979
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Astellas Pharma Europe B.V. 9
Not applicableStudy completedNCT02590250
What this trial is testing

A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India

Who this might be right for
Urinary IncontinenceOveractive Bladder
Allergan 250
Large-scale testing (Phase 3)Active Not RecruitingNCT05621616
What this trial is testing

Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Aged 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Astellas Pharma Global Development, Inc. 7
Not applicableStudy completedNCT03033355
What this trial is testing

Central Nervous System Changes Following OnabotulinumtoxinA Injection in the Bladder

Who this might be right for
Multiple SclerosisLower Urinary Tract SymptomsNeurogenic Bladder+2 more
The Methodist Hospital Research Institute 12
Early research (Phase 1)Study completedNCT02259751
What this trial is testing

Study to Determine Pharmacodynamic Effects and Pharmacokinetics of KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor Overactivity

Who this might be right for
Spinal Cord Injuries
Boehringer Ingelheim 26
Testing effectiveness (Phase 2)UnknownNCT03187795
What this trial is testing

Mirabegron and Oxybutynin Safety and Efficacy Trial in Spinal Cord Injury

Who this might be right for
Spinal Cord InjuriesUrinary Bladder, Neurogenic
Kessler Foundation 62
Large-scale testing (Phase 3)Study completedNCT02751931
What this trial is testing

Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Astellas Pharma Europe B.V. 91
Post-approval studies (Phase 4)Study completedNCT02601287
What this trial is testing

A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients

Who this might be right for
Urinary IncontinenceOveractive Bladder
Allergan 168
Load More Results